Skip to main content
77 posters,
5 topics,
469 authors,
212 institutions
ePostersLive®
by SciGen® Technologies S.A. All rights reserved.
Bari International Conference
Main menu
Home
Posters by ID
Posters by Title
Authors
Affiliations
Sessions
Topics
Search form
Posters
1.01
Cell therapy model in hemophilia B by genetically modified keratinocytes by lentiviral vectors to produce human clotting factor IX.
Isaura Gonzalez Ramos
,
Irving Lara Navarro
,
Luis Jave Suarez
,
Juan Marchal Corrales
,
Antonio Bernad Miana
,
Ana Jaloma Cruz
Guadalajara University, University Center of health sciences, Guadalajara, Jalisco, MexicoWest Biomedical Research Center of Social Security Mexican Institute, Department of Genetics, Tissue Culture, Guadalajara, Jalisco, Mexico
,
Guadalajara University, University Center for agricultural biosciences, Guadalajara, Jalisco, Mexico, West Biomedical Research Center of Social Security Mexican Institute, Department of Genetics, Tissue Culture, Guadalajara, Jalisco, Mexico
,
West Biomedical Research Center of Social Security Mexican Institute, Department of Immunology Guadalajara, Jalisco, Mexico
,
Department of Anatomy and Embryology Faculty of Medicine, Institute of Biopathology and Regenerative Medicine, Biomedical Research Centre (CIBM), University of Granada, Granada, Spain.
,
Head of Department of Regenerative Cardiology Foundation National Centre for Cardiovascular Research Carlos III, Madrid, Spain.
,
Guadalajara University, University Center of health sciences, Guadalajara, Jalisco, Mexico
Poster Presenter:
Isaura González Ramos
Select rating
Give it 1/5
Give it 2/5
Give it 3/5
Give it 4/5
Give it 5/5
Cancel rating
Average:
5
(
1
vote)
1.02
Influence of aPTT reagents on the 1-stage clotting assay activity in human plasma determined for recombinant FIX products
Herbert Gritsch
,
Stefan Romeder-Finger
,
Friedrich Scheiflinger
,
Peter Turecek
Baxter Innovations GmbH, Vienna, Austria
Select rating
Give it 1/5
Give it 2/5
Give it 3/5
Give it 4/5
Give it 5/5
Cancel rating
Average:
3
(
1
vote)
1.03
Does the factor IXa content of factor IX products impact function, safety and efficacy?
Gerald Schrenk
,
Werner Hoellriegl
,
Alexandra Schiviz
,
Hanspeter Rottensteiner
,
Friedrich Scheiflinger
,
Hans Peter Schwarz
,
Peter L. Turecek
,
Eva-Maria Muchitsch
Baxter Innovations GmbH, Vienna, Austria
Select rating
Give it 1/5
Give it 2/5
Give it 3/5
Give it 4/5
Give it 5/5
Cancel rating
No votes yet
The Poster has not been submitted by the Author.
1.04
Association of miR-132 and miR-185 Genes Methylation and their Expression profile with Risk Congenital factor XIII deficiency
Majid Naderi
,
Akbar Dorgalaleh
,
Dor Mohammad Kordi-Tamandani
,
zohreh Rezaei
,
Shaban Alizadeh
,
Peyman Eshghi
,
Shadi Tabibian
Genetic Researcher Center in Non-Communicable Disease, Zahedan University of Medical Sciences
,
Department of Hematology, Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran
,
Department of Biology, University of Sistan and Baluchestan, Zahedan, Iran
,
Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Select rating
Give it 1/5
Give it 2/5
Give it 3/5
Give it 4/5
Give it 5/5
Cancel rating
Average:
3
(
1
vote)
The Poster has not been submitted by the Author.
1.05
Disseminated Intravascular Coagulation a Controversial Clinical Feature in Congenital Factor XIII Deficiency in Southeast of Iran
Majid Naderi
,
Akbar Dorgalaleh
,
Shaban Alizadeh
,
Shadi Tabibian
,
Marzia Menegatti
Genetic Researcher Center in Non-Communicable Disease, Zahedan University of Medical Sciences
,
Department of Hematology, Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran
,
A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS, Ca’ Granda Ospedale Maggiore Policlinico, Department of Pathophysiology Transplantation, University of Milan and Luigi Villa Foundation
Select rating
Give it 1/5
Give it 2/5
Give it 3/5
Give it 4/5
Give it 5/5
Cancel rating
Average:
1
(
1
vote)
1.06
Global Development Plan for a Double Virus Inactivated Fibrinogen Concentrate for the Treatment of Congenital Fibrinogen Deficiency
F Peyvandi
,
B Schwartz
,
S Knaub
,
O Hegener
University of Milan, Milan, Italy
,
Octapharma USA, Inc., Hoboken, USA
,
Octapharma AG, Lachen, Switzerland
Select rating
Give it 1/5
Give it 2/5
Give it 3/5
Give it 4/5
Give it 5/5
Cancel rating
No votes yet
The Poster has not been submitted by the Author.
1.07
Correlation of Genotype and Phenotype in Patients with Rare Bleeding Disorders in Pakistan
Munira Borhany
,
Helena Handrkova
,
Andrea Cairo
,
Naveena Fatima
,
Hira Fatima
,
Arshi Naz
,
Tahir Shamsi
,
Flora Peyvandi
,
Hans Peter Kohler
Department of Haemostasis & Thrombosis, National Institute of Blood Disease & Bone Marrow Transplantation (NIBD), Karachi Pakistan.
,
University Clinic of Haematology, Haemostasis Research Laboratory, University Hospital & University of Bern, Bern, Switzerland
,
U.O.S. Dipartimentale per la Diagnosi e la Terapia delle Coagulopatie, A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione I.R.C.C.S. Cà Granda Ospedale Maggiore Policlinico, Università degli Studi Milano, Italy
,
Department of Research and Development, National Institute of Blood Disease & Bone Marrow Transplantation (NIBD), Karachi Pakistan.
Select rating
Give it 1/5
Give it 2/5
Give it 3/5
Give it 4/5
Give it 5/5
Cancel rating
No votes yet
The Poster has not been submitted by the Author.
1.08
Genotype and Phenotype relationships in 10 Pakistani Unrelated patients with inherited Factor VII deficiency
Munira Borhany
,
H. Boijout
,
J.-l. Pellequer
,
N. Fatima
,
T. Shamsi
,
G. Moulis
,
P. Martinez
,
J.-F. Schved
,
M. Blaizot
Department of haemostasis & thrombosis, national institute of blood disease & bone marrow transplantation, Karachi, Pakistan
,
CHU Montpellier, Département d’hématologie biologique, Hopital Saint-Eloi, Montpellier, France; and Cea, Ibeb, Service de biochimie et toxicologie nucléaire, Bagnols sur Cèze, France
,
Department of research and development,national institute of blood disease & bone marrow transplantation, karachi, Pakistan
Select rating
Give it 1/5
Give it 2/5
Give it 3/5
Give it 4/5
Give it 5/5
Cancel rating
No votes yet
2.02
Defining The Molecular Basis Underlying The Physiological Interaction Between Von Willebrand Factor And Galectins In Normal Plasma
Orla Rawley
,
Jamie O'Sullivan
,
Alain Chion
,
Niamh O'Regan
,
P. Vince Jenkins
,
Teresa Brophy
,
James O'Donnell
Center for HUS prevention, control and management, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy for the North Italian HUS Network
,
Haemostasis Research Group, Institute of Molecular Medicine, St. James's Hospital Campus, Trinity College Dublin, Ireland
,
Haemostasis Research Group, Institute of Molecular Medicine, St. James’s Hospital, Trinity College Dublin, Ireland.
Select rating
Give it 1/5
Give it 2/5
Give it 3/5
Give it 4/5
Give it 5/5
Cancel rating
No votes yet
Pages
1
2
3
4
5
6
7
8
9
next ›
last »